Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
14
Number of overlapping holdings
15.7%
% of WDNA's 91 holdings also in FBT
46.7%
% of FBT's 31 holdings also in WDNA
Overlap by Weight
Sector Drift (WDNA minus FBT)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in FBT |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 1.9% | 5.3% | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 1.3% | 3.2% | 1.3% |
|
REPLIGEN CORP | 1.2% | 3.4% | 1.2% |
|
REGENERON PHARMACEUTICALS | 1.2% | 3.4% | 1.2% |
|
AMGEN INC | 1.1% | 3.0% | 1.1% |
Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to FBT
|
IOVANCE BIOTHERAPEUTICS INC | 3.9% |
|
TWIST BIOSCIENCE CORP. | 3.4% |
|
FATE THERAPEUTICS INC | 3.1% |
 |
NOVOZYMES A/S-B SHARES | 2.4% |
|
BLUEPRINT MEDICINES CORP. | 2.2% |
|
BRIDGEBIO PHARMA, INC. | 2.0% |
|
ELI LILLY & CO | 1.9% |
|
CRISPR THERAPEUTICS AG | 1.8% |
 |
ALCOBRA LTD | 1.7% |
|
VERICEL CORPORATION | 1.7% |
WDNA Underweight Relative to FBT
|
BRUKER CORP | -4.3% |
|
HALOZYME THERAPEUTICS INC | -4.0% |
 |
METTLER-TOLEDO INTERNATIONAL | -3.7% |
|
WATERS CORP | -3.7% |
|
CORCEPT THERAPEUTICS INC | -3.7% |
|
NEUROCRINE BIOSCIENCES INC | -3.5% |
 |
ARGENX SE ADR | -3.5% |
|
INTRA-CELLULAR THERAPIES INC | -3.5% |
|
EXELIXIS INC | -3.4% |
|
NATERA INC | -3.4% |